Structural Formula (Joe00 0002 01)
Joenja Tablet, Film Coated
Product Images NDC 71274-170
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Joenja (NDC 71274-170). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pharming Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Joe00 0002 02)
This is a statistical report presenting results of a study that includes demographic data of study participants split by age groups, and comparing the results of a new treatment (JOENJA) to a placebo. The report provides values for various statistical tests, including confidence intervals, differences, and percentages.*
Principal Display Panel – 60 Tablet Carton Label (Joe00 0002 03)
This is a description of a drug called "Joenja" in tablet form. Each tablet contains 70mg of Leniolisib which is equivalent to 85.26mg of Leniolisib Phosphate. It is intended to be used as per the prescribing information and needs to be stored within the specified temperature range of 20° to 25°C (68° to 77°F) with excursions permitted between 1570 30°C (59° to 86°F). It should not be refrigerated and should be stored in the original container, out of reach of children. The drug is exclusively available only on prescription.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
